According to KORU Medical Systems's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -18.9412. At the end of 2022 the company had a P/E ratio of -17.9.
Year | P/E ratio | Change |
---|---|---|
2022 | -17.9 | -40.5% |
2021 | -30.0 | -85.05% |
2020 | -201 | -154.61% |
2019 | 367 | 416.5% |
2018 | 71.1 | |
2016 | -101 | -517.53% |
2015 | 24.2 | 15.61% |
2014 | 21.0 | -4.34% |
2013 | 21.9 | 90.43% |
2012 | 11.5 | -11.54% |
2011 | 13.0 | -2.99% |
2010 | 13.4 | -29.47% |
2009 | 19.0 | 216.67% |
2008 | 6.00 | -68.42% |
2007 | 19.0 | -1240% |
2006 | -1.67 | -69.7% |
2005 | -5.50 | -45% |
2004 | -10.0 | 3034.33% |
2003 | -0.3190 | -75.6% |
2002 | -1.31 | -77.29% |
2001 | -5.76 |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.